review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.VPH.2006.08.004 |
P698 | PubMed publication ID | 17046334 |
P2093 | author name string | Una S Ryan | |
Charles W Rittershaus | |||
P2860 | cites work | Cholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atherosclerosis | Q28209813 |
Immunization with cholesterol-rich liposomes induces anti-cholesterol antibodies and reduces diet-induced hypercholesterolemia and plaque formation | Q28275313 | ||
Inhibition of atherosclerosis in apoE-null mice by immunization with apoB-100 peptide sequences | Q31135771 | ||
Immunomodulation of atherosclerosis: implications for vaccine development | Q34363173 | ||
Effects of cholesteryl ester transfer protein inhibition on high-density lipoprotein subspecies, apolipoprotein A-I metabolism, and fecal sterol excretion. | Q35590298 | ||
Antibody against cholesteryl ester transfer protein (CETP) elicited by a recombinant chimeric enzyme vaccine attenuated atherosclerosis in a rabbit model | Q40413205 | ||
Vaccinating rabbits with a cholesteryl ester transfer protein (CETP) B-Cell epitope carried by heat shock protein-65 (HSP65) for inducing anti-CETP antibodies and reducing aortic lesions in vivo | Q40422178 | ||
The safety and immunogenicity of a CETP vaccine in healthy adults | Q40574796 | ||
Cost-effectiveness of gemfibrozil for coronary heart disease patients with low levels of high-density lipoprotein cholesterol: the Department of Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial | Q43861369 | ||
Prototype Alzheimer's disease vaccine using the immunodominant B cell epitope from beta-amyloid and promiscuous T cell epitope pan HLA DR-binding peptide | Q45295828 | ||
Effectiveness of inhibition of cholesteryl ester transfer protein by JTT-705 in combination with pravastatin in type II dyslipidemia | Q46447595 | ||
Dibenzodioxocinones--a new class of CETP inhibitors | Q46564413 | ||
Medication adherence trends with statins | Q46601441 | ||
A Low Prevalence of Coronary Heart Disease among Subjects with Increased High-Density Lipoprotein Cholesterol Levels, Including Those with Plasma Cholesteryl Ester Transfer Protein Deficiency | Q61962950 | ||
Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report | Q63694274 | ||
Cholesterol vaccines | Q72409332 | ||
Vaccine-induced antibodies inhibit CETP activity in vivo and reduce aortic lesions in a rabbit model of atherosclerosis | Q74290884 | ||
Contraceptive vaccines | Q81479017 | ||
Current Drug Options for Raising HDL Cholesterol | Q81780645 | ||
P433 | issue | 5 | |
P304 | page(s) | 253-257 | |
P577 | publication date | 2006-08-17 | |
P1433 | published in | Vascular Pharmacology | Q7916446 |
P1476 | title | Vaccines for the prevention of cardiovascular disease | |
P478 | volume | 45 |
Q40967621 | A novel atheroprotective role of MF59-like adjuvant when co-administered with CETP vaccine in rabbit model of atherosclerosis |
Q39215603 | Coagulation factor XI vaccination: an alternative strategy to prevent thrombosis |
Q34634698 | Peptide-based anti-PCSK9 vaccines - an approach for long-term LDLc management |
Q79163371 | Proceedings of the 8th International Conference on the Vascular Endothelium: Translating Discoveries into Public Health Practice--part I |
Q57821678 | Recent Advances in the Development of Vaccines for Diabetes, Hypertension, and Atherosclerosis |
Q37530710 | Vaccination for atherosclerosis |
Q43251127 | Vaccination, atherosclerosis and systemic lupus erythematosus |
Search more.